Abemaciclib methanesulfonate

Abemaciclib methanesulfonate (订货以英文为准)

编号:L124851
CAS号:1231930-82-7
分子式:C27H32F2N8.CH4O3S
分子量:602.70
货号 品牌 包装 目录价 您的价格 库存 数量 购买
L124851-250mg 阿拉丁 250mg ¥249.90
L124851-10mg 阿拉丁 10mg ¥39.90
L124851-50mg 阿拉丁 50mg ¥89.90
L124851-5mg 阿拉丁 5mg ¥29.90
L124851-25mg 阿拉丁 25mg ¥52.90
L124851-100mg 阿拉丁 100mg ¥129.90
L124851-1g 阿拉丁 1g ¥649.90
产品名称 Abemaciclib methanesulfonate
中文名称 Abemaciclib methanesulfonate
CAS号 1231930-82-7
分子式(M.F.) C27H32F2N8.CH4O3S
分子量(M.W.) 602.70
储存条件 -20°C储存
溶解性DMSO 83 mg/mL Water 100 mg/mL Ethanol 24 mg/mL
存贮条件储存温度-20°C
产品介绍LY2835219对CDK4和CDK6的IC50分别为2 nM和10 nM。
生化机理LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. CDK4/6 dual inhibitor LY2835219 specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation in early G1. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S phase transition, thereby arresting the cell cycle in the G1 phase, suppressing DNA synthesis and inhibiting cancer cell growth. Overexpression of the serine/threonine kinases CDK4/6, as seen in certain types of cancer, causes cell cycle deregulation.
别名LY2835219;LY 2835219;LY-2835219;N-[5-[(4-乙基-1-哌嗪基)甲基]-2-吡啶基]-5-氟-4-[4-氟-2-甲基-1-异丙基-1H-苯并咪唑-6-基]-2-嘧啶胺甲烷磺酸盐;CDK4/6 dual inhibitor;LY 2835219;LY-2835219;N-[5-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinamine methanesulfonate (1:1)
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:13823-29-5
¥ 219.00 R055300-10g
CAS号:67-63-0
¥ 289.00 801092190-5L
CAS号:23696-28-8
¥ 650.00 O815287-100mg
CAS号:1577-22-6
¥ 200.00 AK001PYI-10g
¥ 135.00 36122ES60-100mL
¥ 100.00 GDS180S-1张
CAS号:593-51-1
¥ 28.50 01092862-100g